These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 11840264)

  • 81. Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies.
    Fischer E; Chaitanya K; Wüest T; Wadle A; Scott AM; van den Broek M; Schibli R; Bauer S; Renner C
    Clin Cancer Res; 2012 Nov; 18(22):6208-18. PubMed ID: 22992515
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
    Buchsbaum DJ; Lawrence TS; Roberson PL; Heidorn DB; Ten Haken RK; Steplewski Z
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):629-38. PubMed ID: 8454481
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The rationale for and background of radioimmunotherapy: an emerging therapy for B-cell non-Hodgkin's lymphoma.
    Riley MB; Byar K
    Semin Oncol Nurs; 2004 Feb; 20(1 Suppl 1):1-7. PubMed ID: 15160855
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
    Sharkey RM; Behr TM; Mattes MJ; Stein R; Griffiths GL; Shih LB; Hansen HJ; Blumenthal RD; Dunn RM; Juweid ME; Goldenberg DM
    Cancer Immunol Immunother; 1997 May; 44(3):179-88. PubMed ID: 9191878
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Contribution of radioimmunotherapy to the treatment of lymphoma].
    Rizzo-Padoin N
    Ann Pharm Fr; 2008; 66(5-6):300-8. PubMed ID: 19061730
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
    Janssen ML; Pels W; Massuger LF; Oyen WJ; Boonstra H; Corstens FH; Boerman OC
    Int J Gynecol Cancer; 2003; 13(5):607-13. PubMed ID: 14675343
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy.
    Jandl T; Revskaya E; Jiang Z; Harris M; Dorokhova O; Tsukrov D; Casadevall A; Dadachova E
    Nucl Med Biol; 2013 Feb; 40(2):177-81. PubMed ID: 23146306
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs.
    Demidem A; Lam T; Alas S; Hariharan K; Hanna N; Bonavida B
    Cancer Biother Radiopharm; 1997 Jun; 12(3):177-86. PubMed ID: 10851464
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines.
    Liu XY; Pop LM; Tsai L; Pop IV; Vitetta ES
    Int J Cancer; 2011 Jul; 129(2):497-506. PubMed ID: 20878959
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
    Pagel JM; Hedin N; Subbiah K; Meyer D; Mallet R; Axworthy D; Theodore LJ; Wilbur DS; Matthews DC; Press OW
    Blood; 2003 Mar; 101(6):2340-8. PubMed ID: 12446461
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Radioimmunotherapy with 90Y-ibritumomab tiuxetan in lymphomas].
    Setoain X; López-Guillermo A; Ruiz A; Pons F
    Rev Esp Med Nucl; 2006; 25(1):55-68; quiz 69-70.. PubMed ID: 16540015
    [No Abstract]   [Full Text] [Related]  

  • 92. Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel.
    Ning S; Trisler K; Brown DM; Yu NY; Kanekal S; Lundsten MJ; Knox SJ
    Radiother Oncol; 1996 May; 39(2):179-89. PubMed ID: 8735485
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.
    Johnson TA; Press OW
    Int J Cancer; 2000 Jan; 85(1):104-12. PubMed ID: 10585592
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
    Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Monoclonal antibodies in the treatment of lymphoid malignancies.
    Tsirigotis P; Economopoulos T
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):267-71. PubMed ID: 17935974
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
    Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
    Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study.
    Vandenbulcke K; Thierens H; Offner F; Janssens A; de Gelder V; Bacher K; Philippé J; De Vos F; Dierckx R; Apostolidis C; Morgenstern A; Slegers G
    Nucl Med Commun; 2004 Nov; 25(11):1131-6. PubMed ID: 15577593
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
    Hernandez MC; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1274-87. PubMed ID: 15275710
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
    Ben Abdelwahed R; Donnou S; Ouakrim H; Crozet L; Cosette J; Jacquet A; Tourais I; Fournès B; Gillard Bocquet M; Miloudi A; Touitou V; Daussy C; Naud MC; Fridman WH; Sautès-Fridman C; Urbain R; Fisson S
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3657-65. PubMed ID: 23611989
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with
    Yoon JT; Longtine MS; Marquez-Nostra BV; Wahl RL
    J Nucl Med; 2018 Aug; 59(8):1219-1224. PubMed ID: 29348316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.